The Plus SideZ: A GLP-1 Guide to Metabolic Health

Linktree for Community Resources
Need help appealing a GLP-1 Insurance Denial?
FindHonestCare.com/Kim

Ro - Telehealth for GLP1 Weight Management

The Absolute Lies You’ve Heard About GLP-1s (Ozempic Myths Debunked) [REPLAY]
Are you being lied to about Ozempic, Mounjaro, and Wegovy? In this special replay episode, leading obesity medicine specialists break down the biggest GLP-1 myths taking over your feed. We are reposting this crucial conversation because it is more relevant than ever. With GLP-1 price changes and expanding access options through federal programs like the Medicare GLP-1 Bridge, understanding the real science behind these medications is essential for patient advocacy.

We are sharing a few favorite replay episodes right now while Kim is away on bereavement leave following the loss of her sister. We want to deeply thank our subscribers for staying engaged and supporting the show during this time.

In this episode of The Plus Sidez Podcast, Kat joins Kim to sit down with obesity medicine specialists Dr. Matea Rentea and Dr. Ali Novitzki to help listeners better understand their disease and feel empowered in their healthcare journey.

The Myths We Debunk:
The Muscle Loss Scare: The data behind weight loss and body composition, explaining why the medication itself is not destroying your lean mass.
The Willpower Narrative: Why obesity is a genetic, chronic metabolic disease rooted in brain biology, not a failure of personal willpower.
The Shot-Only Illusion: How the medication works alongside your body's natural satiety signals and gut receptors.

Obesity Doctor Guidance Shared:
Metabolic Protection: A practical discussion on utilizing a 10-minute fitness routine and a 100-gram protein framework to maintain lean mass and support insulin sensitivity.
System Navigation: Insights on navigating insurance barriers, managing prior authorizations, and advocating for proper medical care.
Mental Resilience: Tools to process unsolicited comments about your weight and protect your peace from societal judgment.

Episode Topics:

Why We Are Replaying This Episode: Prices, Access, and Updates
The Insurance Landscape: Understanding Prior Authorizations
Meet the Obesity Medicine Specialists
Deconstructing the GLP-1 Muscle Loss Narrative
Strategies for Protecting Your Metabolism
What the Scales Do Not Show About Insulin Resistance
Natural Satiety Triggers and Gut Receptors
Recognizing Obesity as a Biological Chronic Disease
Addressing Weight Stigma and External Commentary

Subscribe to The Plus Sidez Podcast for science-backed episodes breaking down metabolic health, body recomposition, and the truth about weight loss.

Search Tags
GLP1 lies debunked, Ozempic myths, Mounjaro weight loss journey, Wegovy truth, Zepbound body recomposition, insulin sensitivity hacks, natural GLP1 boosters, treating obesity metabolic disease, plus sidez podcast, dr matea rentea, dr ali novitzki
_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer 
TikTok
Instagram 
Kat Carter,  Producer 
TikTok
Instagram

Linktree for Community Resources

Need help appealing your GLP-1 insurance denials?
Try findhonestcare.com/kim

Ro - Telehealth for GLP1 Weight Management
_________________________________________________________________________

GLP-1 Over 60: Why This Feels Different Now Part 2
***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode.

What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work?

In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around.

As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age.

What we cover:

- GLP-1 weight loss over 60
- Food noise and obesity beyond willpower
- Diet culture and lifelong messaging around weight
- Grief, stress, and emotional eating
- Protein, muscle preservation, and aging on GLP-1s
- Side effects and realistic expectations

Follow Deb

Follow Dr. Ogle
_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer 
TikTok
Instagram 
Kat Carter,  Producer 
TikTok
Instagram

Linktree for Community Resources

Need help appealing your GLP-1 insurance denials?
Try findhonestcare.com/kim

Ro - Telehealth for GLP1 Weight Management and GLP-1

_________________________________________________________________________
***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode.

What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work?

In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around.

As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age.

What we cover:

- GLP-1 weight loss over 60
- Food noise and obesity beyond willpower
- Diet culture and lifelong messaging around weight
- Grief, stress, and emotional eating
- Protein, muscle preservation, and aging on GLP-1s
- Side effects and realistic expectations

Follow Deb

Follow Dr. Ogle

_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer 
TikTok
Instagram 
Kat Carter,  Producer 
TikTok
Instagram

Linktree for Community Resources

Need help appealing GLP-1 insurance denials?
findhonestcare.com/kim

Ro - Telehealth for GLP1 Weight Management
Ro.Co/PlusSideZ
_________________________________________________________________________

What if millions of women with PCOS were misunderstood for years because the condition was treated mainly as a reproductive disorder instead of a metabolic disease tied to insulin resistance, obesity, hormones, and fertility?

In this episode of The Plus SideZ Podcast, Dr. Melanie Cree, a pediatric endocrinologist, obesity researcher, and PCOS/PMOS expert, explains the recent global consensus to rename PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect the condition’s metabolic and hormonal impact.

Dr. Cree breaks down how delayed diagnosis and outdated understanding may have prevented many patients from getting earlier metabolic treatment and intervention.

We discuss:
Why so many women with PCOS were misunderstood or dismissed
The connection between PCOS, PMOS, insulin resistance, obesity, and fertility
Why weight gain is not just about willpower
Adolescent PCOS and why early intervention matters
GLP-1 medications like semaglutide for PCOS/PMOS
Emerging research focused on ovulation, fertility, and metabolic health
How hormones, appetite, and metabolism are connected
Why the PMOS name change could improve diagnosis and treatment

Dr. Cree also shares information about her ongoing research and studies exploring how GLP-1 medications may help improve metabolic and reproductive health in people with PCOS/PMOS.

Learn more about studies 
https://medschool.cuanschutz.edu/pediatrics/sections/endocrinology/endocrinology-research/cree-lab/Cree-Melanie-UCD4665?utm_source=chatgpt.com

_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer 
TikTok
Instagram 
Kat Carter,  Producer 
TikTok
Instagram

Linktree for Community Resources

Need help appealing GLP-1 Insurance Denials? Try Honest Care! www.findhonestcare.com/Kim

Ro - Telehealth for GLP1 Weight Management

_________________________________________________________________________

This week, we’re revisiting one of the most powerful conversations in Plus SideZ Podcast history with Rosie O'Donnell.

As Kim takes time away following the loss of her sister, we’re sharing a few meaningful “greatest hits” episodes that continue to resonate deeply with listeners. Thank you for continuing to support, download, watch, and share the podcast during this difficult time. This community means more than you know.

In this replay, Rosie opens up about:

- Lifelong struggles with weight and obesity
- How the media treated her body over the years
- Bariatric surgery and her experience after surgery
- Emotional eating, shame, and public scrutiny
- What it feels like to navigate weight and health over 60
- Her experience with GLP-1 medications and changing obesity treatment

As conversations around GLP-1 medications continue to grow, especially with major Medicare coverage changes expected to expand in July 2026, this episode feels more relevant than ever. For many adults over 60, questions about obesity treatment, metabolism, bariatric surgery, and whether GLP-1s can still work after decades of dieting are finally entering the mainstream.

This episode goes beyond headlines and before-and-after stories. It’s an honest conversation about biology, stigma, survival, and what happens when people living with obesity are finally heard with compassion instead of judgment.

If you’ve ever wondered:

- Do GLP-1 medications work differently over 60?
- Can GLP-1s help after bariatric surgery?
- Why does weight loss feel harder with age?
- How much of obesity is biology versus willpower?

…this conversation is for you.

Listen now wherever you get your podcasts and subscribe to The Plus SideZ Podcast for more conversations that validate lived experience with science, honesty, and empathy.

_________________________________________________________________________

Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join

_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer 
TikTok
Instagram 
Kat Carter,  Producer 
TikTok
Instagram